U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07446153) titled 'A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects' on Feb. 26.
Brief Summary: This study is an open, multicenter, Phase I/II clinical trial, divided into three stages: dose escalation, dose expansion and efficacy expansion.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Solid Tumor
Intervention:
DRUG: HRS-8364 Tablet
HRS-8364 tablet.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....